In the current case, the antifungal susceptibility results for the case isolate were similar to those previously reported in the literature (1, 5, 9), i.e., the strain was sensitive to VRC. Due to his economic condition, we initially treated him with VRC but then used FLC and AMB for longer-term therapy. His headache and fever improved; however, the patient still complained of acroanesthesia after 1 year of follow-up. We attribute his recovery to the use of antifungal drugs and the improvement of his living standard. Nevertheless, we do not know whether the use of FLC and AMB was effective in the present case.